Oramed Pharmaceuticals Inc. ORMP
Set alert
4.04 USD +0.04 +1.00%
As of Nov 3, 10:21 AM ET
4.02 Day range 4.05
2.09 52-week range 5.47
- YTD
- +41.75%
- 1 year
- +71.19%
- Open
- 4.02
- Prev close
- 4.00
- Mkt cap
- 165.34M
- Vol
- 9.80K
- Avg vol
- 178.58K
- EPS
- 4.13
- P/E
- 0.98
- Div yield
- 5.91%
More statistics
- Low
- 4.02
- High
- 4.05
- Forward P/E
- -29.75
- Beta
- 1.77
- Short ratio
- 2.60
- Inst. own
- 17.52%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.38
- 200-d avg
- 2.43
- 1y target
- 3.25
5D chart
Signals (56)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:55 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 1:45 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 1:35 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 10:50 AM | 23 hours ago |
| SMA: Bullish | Nov 2, 10:45 AM | 23 hours ago |
| SMA: Bearish | Nov 2, 9:45 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 9:45 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 3:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:30 PM | 3 days ago |
Newest 20 of 56.
Financial health
Altman Z-Score
3.38 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
S-5 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 5
- P/E 4
- P/B 5
Valuation
P/E 1.9×
FY 2015 5y median -5.0× FY 2025
P/S 59.0×
FY 2015 5y median 69.5× FY 2025
P/B 0.6×
FY 2015 5y median 0.7× FY 2025
P/FCF -10.7×
FY 2015 5y median -11.7× FY 2025
EV/EBITDA 1.0×
FY 2015 5y median -3.0× FY 2025
EV/Sales 36.4×
FY 2015 5y median 101× FY 2025
FCF Yield -9.4%
FY 2015 5y median -8.5% FY 2025
Profitability
Gross Margin 0.7%
FY 2015 5y median 100.0% FY 2025
Operating Margin -754.4%
FY 2015 5y median -896.2% FY 2025
Net Margin 3202.5%
FY 2015 5y median 0.0% FY 2025
ROE 32.1%
FY 2015 5y median -13.0% FY 2025
ROIC -6.0%
FY 2015 5y median -8.5% FY 2025
ROA 27.7%
FY 2015 5y median -12.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2015 FY 2025
Operating Income -18.1%
FY 2015 FY 2025
EPS (diluted) 412.5%
FY 2015 FY 2025
Free Cash Flow -31.4%
FY 2015 FY 2025
Financial Health
Current Ratio 7.0×
FY 2015 5y median 14.3× FY 2025
Quick Ratio 7.0×
FY 2015 5y median 14.3× FY 2025
Debt / Equity 0.0×
FY 2015 5y median 0.0× FY 2025
Net Debt / EBITDA -0.6×
FY 2015 5y median 3.2× FY 2025
Interest Coverage 0.0×
FY 2015 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
